Gene
Chromosome localization
Polymorphism
Position in gene
Allele/Genotype/Haplotype associated with disease
Clinical picture
Functional alterations
Population studied
Ref.
MBL2
10q11.2-q21
-221 X,Y A (52C, 54G, 57G), O (52T, 54A, 57A)
Promoter and exon 1
YA/YA, YA/XA
RHD - MS
High production of MBL
Brazilian
7
A (52C, 54G, 57G), O (52T, 54A, 57A)
O, O/O
RHD - AR
Low level of MBL in sera
8
FCN2
9q34
-986G/A, -602G/A, -4G/A
promoter
G/G/A
RHD
Low levels of ficolin 2
9
TLR2
4q32
2258A/G (753 Arg/Gln)
exon 3
753Gln, Arg753Gln
ARF
Low level of pathogen recognition
Turkish
10
FCγRIIA
1q21-q23
494A/G (131H/R)
exon 4
131R, R/R (high risk), R/H (intermediate risk)
Low ability of binding human IgG2
14
IL1RA
2q14.2
A1,A2,A3,A4
Intron 2
A1/A1
Low level of receptor expression
Egyptian
16
A1, A1/A1
17
TNFα
6p21.3
-308G/A
A
Th1/Th2 imbalance
Mexican
20
A/A
RHD-MVL
A/A, G/G
RHD-MVD
ARF/RHD
18
High production of TNF alpha
19
-238G/A
G, G/G
TGFβ
19q13.1
-509C/T
T
24
C/C
HD x RHD
Protection to RHD
Chinese
23
869T/C
Exon 1
T, T/T
IL-10
1q31-q32
-1082G/A
G/G
CTLA4
+49A/G
CTLA-4 affected inhibitory function
25